Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular risk drives cognitive decline over 10 years in people aging with well-controlled HIV.

AIDS (London, England)·2026
Same author

What factors influence ratings of Global Perceived Effect by individuals with low back pain and physiotherapists?

The journal of pain·2026
Same author

Quantifying the Degree of Fatigue in People Reporting Symptoms of Post-COVID-19 Syndrome: Results from a Rasch Analysis.

Physiotherapy Canada. Physiotherapie Canada·2026
Same author

The influence of frailty on co-medication network structures and anticholinergic burden in people living with HIV.

Research in social & administrative pharmacy : RSAP·2026
Same author

Psychometric Properties of the 4-Metre Walk Test in the Canadian Longitudinal Study on Aging.

Canadian journal on aging = La revue canadienne du vieillissement·2026
Same author

Discriminating Between Fallers and Non-Fallers Using Kinematic Data from the Heel2Toe™ Wearable Sensor.

Sensors (Basel, Switzerland)·2026
Same journal

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Epiretinal membranes in multiple sclerosis: A window into glial pathobiology?

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same journal

Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Methods and measures: what's new for MS?

Nancy E Mayo1, Stanley Hum, Ayse Kuspinar

  • 1School of Physical and Occupational Therapy, Faculty of Medicine, McGill University, Canada. nancy.mayo@mcgill.ca

Multiple Sclerosis (Houndmills, Basingstoke, England)
|December 22, 2012
PubMed
Summary
This summary is machine-generated.

Accurate health outcome measurement is crucial for multiple sclerosis (MS) treatment. Patient-reported outcomes, using well-designed questions and Rasch Measurement Theory, provide vital data for assessing MS progression and treatment impact.

Keywords:
Multiple sclerosisfatigueoutcome measurementquality of life

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Related Experiment Videos

Last Updated: May 15, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Area of Science:

  • Neurology
  • Health Outcomes Research
  • Psychometrics

Background:

  • Accurate measurement of health outcomes is critical in multiple sclerosis (MS) due to numerous available and emerging interventions.
  • Biological parameters alone are insufficient for assessing all meaningful outcomes in MS.
  • Patient-reported outcomes are essential for capturing the impact of MS on quality of life.

Purpose of the Study:

  • To highlight the importance of accurate health outcome measurement in multiple sclerosis (MS).
  • To emphasize the role of patient-reported outcomes in clinical decision-making for MS.
  • To introduce psychometric approaches for robust outcome assessment in MS.

Main Methods:

  • Utilizing patient-reported outcomes through direct questioning to assess key constructs like fatigue, depression, and pain.
  • Applying Rasch Measurement Theory to ensure questionnaire items form a linear continuum for reliable scoring.
  • Employing preference-based measures derived from patients to value health dimensions impacted by MS.

Main Results:

  • Consistent collection of patient-reported data using well-formulated questions yields historically accurate insights into MS progression.
  • Rasch Measurement Theory validates the psychometric properties of outcome measures, enabling accurate scoring.
  • Patient-derived preference measures effectively capture the multifaceted impact of MS on individuals' lives.

Conclusions:

  • The quality of questions asked directly influences the reliability and validity of health outcome data in MS.
  • Patient-centered outcome measurement, supported by sound psychometric principles, is indispensable for effective MS management.
  • Accurate assessment of patient-reported outcomes is key to understanding treatment efficacy and guiding clinical decisions in multiple sclerosis.